Movement Alert｜WuXi XDC Falls 3.07% in Regular Trading, Morgan Stanley Cuts Target Price to HK$80

Market Focus

Jul 07

On July 7, WuXi XDC (02268.HK) declined 3.07% in regular trading, trading at HK$61.6/share, with turnover of HK$147 million.

On the news front, Morgan Stanley published a report on July 6 cutting WuXi XDC's target price from HK$83 to HK$80, while downgrading earnings forecasts for 2026 through 2030 by approximately 0-7%. The revision primarily reflects the consolidation of Dongyao Pharma's Q2 financials, which introduces lower gross margins and additional financial expenses, as well as the impact of USD depreciation against the RMB on exchange costs. Morgan Stanley maintained its Overweight rating on the stock.

The broader Life Sciences Tools and Services sector also traded weaker, with WuXi AppTec down 2.7%, WuXi Biologics down 2.17%, Insilico Medicine down 6.09%, and XtalPi down 3.79%, indicating broad-based sector pressure alongside the company-specific downgrade.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/1135436150"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1135436150\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1135436150?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-07 13:17","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1135436150","market":"us","top_or_hot":-1,"title":"Movement Alert｜WuXi XDC Falls 3.07% in Regular Trading, Morgan Stanley Cuts Target Price to HK$80","media":"Market Focus","content":"<p><p>On July 7, WuXi XDC (02268.HK) declined 3.07% in regular trading, trading at HK$61.6/share, with turnover of HK$147 million.</p><p>On the news front, Morgan Stanley published a report on July 6 cutting WuXi XDC's target price from HK$83 to HK$80, while downgrading earnings forecasts for 2026 through 2030 by approximately 0-7%. The revision primarily reflects the consolidation of Dongyao Pharma's Q2 financials, which introduces lower gross margins and additional financial expenses, as well as the impact of USD depreciation against the RMB on exchange costs. Morgan Stanley maintained its Overweight rating on the stock.</p><p>The broader Life Sciences Tools and Services sector also traded weaker, with WuXi AppTec down 2.7%, WuXi Biologics down 2.17%, Insilico Medicine down 6.09%, and XtalPi down 3.79%, indicating broad-based sector pressure alongside the company-specific downgrade.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜WuXi XDC Falls 3.07% in Regular Trading, Morgan Stanley Cuts Target Price to HK$80</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜WuXi XDC Falls 3.07% in Regular Trading, Morgan Stanley Cuts Target Price to HK$80\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-07 13:17</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 7, WuXi XDC (02268.HK) declined 3.07% in regular trading, trading at HK$61.6/share, with turnover of HK$147 million.</p><p>On the news front, Morgan Stanley published a report on July 6 cutting WuXi XDC's target price from HK$83 to HK$80, while downgrading earnings forecasts for 2026 through 2030 by approximately 0-7%. The revision primarily reflects the consolidation of Dongyao Pharma's Q2 financials, which introduces lower gross margins and additional financial expenses, as well as the impact of USD depreciation against the RMB on exchange costs. Morgan Stanley maintained its Overweight rating on the stock.</p><p>The broader Life Sciences Tools and Services sector also traded weaker, with WuXi AppTec down 2.7%, WuXi Biologics down 2.17%, Insilico Medicine down 6.09%, and XtalPi down 3.79%, indicating broad-based sector pressure alongside the company-specific downgrade.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02268","symbol_name":"药明合联","start_time":0,"source_url":"","article_id":"1135436150","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1135436150","pubTimestamp":1783401452,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 7, WuXi XDC (02268.HK) declined 3.07% in regular trading, trading at HK$61.6/share, with turnover of HK$147 million.On the news front, Morgan Stanley published a report on July 6 cutting WuXi...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02268":"药明合联"},"translate_title":"动向提示|药明XDC常规交易跌3.07%大摩下调目标价至80港元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02268":1},"content_text":"On July 7, WuXi XDC (02268.HK) declined 3.07% in regular trading, trading at HK$61.6/share, with turnover of HK$147 million.On the news front, Morgan Stanley published a report on July 6 cutting WuXi XDC's target price from HK$83 to HK$80, while downgrading earnings forecasts for 2026 through 2030 by approximately 0-7%. The revision primarily reflects the consolidation of Dongyao Pharma's Q2 financials, which introduces lower gross margins and additional financial expenses, as well as the impact of USD depreciation against the RMB on exchange costs. Morgan Stanley maintained its Overweight rating on the stock.The broader Life Sciences Tools and Services sector also traded weaker, with WuXi AppTec down 2.7%, WuXi Biologics down 2.17%, Insilico Medicine down 6.09%, and XtalPi down 3.79%, indicating broad-based sector pressure alongside the company-specific downgrade.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}